Promis Neurosciences Inc (PMN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,736 | -2,462 | -1,314 | -5,574 | -4,502 |
| Depreciation Amortization | 4 | 2 | 1 | 7 | 4 |
| Accounts receivable | 11 | 25 | 4 | -15 | 12 |
| Other Working Capital | 910 | 373 | 120 | 490 | 535 |
| Other Operating Activity | 244 | 182 | 155 | 503 | 403 |
| Operating Cash Flow | $-2,567 | $-1,879 | $-1,035 | $-4,589 | $-3,549 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -78 | N/A | N/A | N/A | N/A |
| Purchase Of Investment | -2 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $-80 | $N/A | $N/A | $0 | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 1,650 | 1,585 | 714 | 4,515 | 2,008 |
| Other Financing Activity | 0 | 0 | 0 | -474 | 0 |
| Financing Cash Flow | $1,650 | $1,585 | $714 | $4,041 | $2,008 |
| Beginning Cash Position | 1,247 | 1,199 | 1,239 | 1,801 | 1,810 |
| End Cash Position | 250 | 905 | 919 | 1,252 | 270 |
| Net Cash Flow | $-998 | $-294 | $-320 | $-549 | $-1,540 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,567 | -1,879 | -1,035 | -4,589 | -3,549 |
| Capital Expenditure | -78 | N/A | N/A | N/A | N/A |
| Free Cash Flow | -2,645 | -1,879 | -1,035 | -4,589 | -3,549 |